Literature DB >> 30618150

Differential diagnoses for sepsis-induced disseminated intravascular coagulation: communication from the SSC of the ISTH.

T Iba1, J H Levy2, H Wada3, J Thachil4, T E Warkentin5, M Levi6.   

Abstract

Entities:  

Mesh:

Year:  2019        PMID: 30618150     DOI: 10.1111/jth.14354

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  15 in total

1.  Increased respiratory dead space could associate with coagulation activation and poor outcomes in COVID-19 ARDS.

Authors:  Jerónimo Graf; Rodrigo Pérez; René López
Journal:  J Crit Care       Date:  2022-06-17       Impact factor: 4.298

2.  Maintaining Hemostatic Balance in Treating Disseminated Intravascular Coagulation.

Authors:  Ashley C Brown; Jerrold H Levy
Journal:  Anesthesiology       Date:  2019-09       Impact factor: 7.892

Review 3.  Thrombomodulin in disseminated intravascular coagulation and other critical conditions-a multi-faceted anticoagulant protein with therapeutic potential.

Authors:  Takashi Ito; Jecko Thachil; Hidesaku Asakura; Jerrold H Levy; Toshiaki Iba
Journal:  Crit Care       Date:  2019-08-15       Impact factor: 9.097

4.  Arterial Thrombotic Events in Adult Inpatients With COVID-19.

Authors:  Morgane Fournier; Dorothée Faille; Antoine Dossier; Arthur Mageau; Pascale Nicaise Roland; Nadine Ajzenberg; Raphael Borie; Lila Bouadma; Vincent Bunel; Yves Castier; Christophe Choquet; Bruno Crestani; Eric Daugas; Laurene Deconinck; Diane Descamps; Vincent Descamps; Philippe Dieudé; Gregory Ducrocq; Nathalie Faucher; Tiphaine Goulenok; Céline Guidoux; Antoine Khalil; Philippa Lavallée; François Xavier Lescure; Brice Lortat-Jacob; Hervé Mal; Pierre Mutuon; Quentin Pellenc; Philippe Gabriel Steg; Camille Taille; Jean Francois Timsit; Yazdan Yazdanpanah; Thomas Papo; Karim Sacré
Journal:  Mayo Clin Proc       Date:  2020-11-27       Impact factor: 7.616

Review 5.  COVID-19 versus HIT hypercoagulability.

Authors:  Theodore E Warkentin; Scott Kaatz
Journal:  Thromb Res       Date:  2020-08-10       Impact factor: 3.944

Review 6.  The dynamic association between COVID-19 and chronic disorders: An updated insight into prevalence mechanism and therapeutic modalities.

Authors:  Shatha K Alyammahi; Shifaa M Abdin; Dima W Alhamad; Sara M Elgendy; Amani T Altell; Hany A Omar
Journal:  Infect Genet Evol       Date:  2020-11-29       Impact factor: 3.342

7.  Expert consensus on the diagnosis and treatment of thrombocytopenia in adult critical care patients in China.

Authors:  Jing-Chun Song; Shu-Yuan Liu; Feng Zhu; Ai-Qing Wen; Lin-Hao Ma; Wei-Qin Li; Jun Wu
Journal:  Mil Med Res       Date:  2020-04-03

Review 8.  COVID-19 and diabetes mellitus: from pathophysiology to clinical management.

Authors:  Soo Lim; Jae Hyun Bae; Hyuk-Sang Kwon; Michael A Nauck
Journal:  Nat Rev Endocrinol       Date:  2020-11-13       Impact factor: 47.564

9.  Editorial commentary: Vascular injury in acute infections and COVID-19: everything old is new again.

Authors:  Jerrold H Levy; Toshiaki Iba; Jean M Connors
Journal:  Trends Cardiovasc Med       Date:  2020-10-28       Impact factor: 6.677

10.  COVID-19 and its implications for thrombosis and anticoagulation.

Authors:  Jean M Connors; Jerrold H Levy
Journal:  Blood       Date:  2020-06-04       Impact factor: 25.476

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.